Ark Invest, through its ARK Fintech Innovation ETF ARKF -5.46% + Free Alerts , bought 162,143 shares of Nu Holdings Ltd. This marks a significant investment in the fintech company, reflecting Ark’s ...

ARK Genomic Revolution ETF (BATS:ARKG – Get Free Report) was the target of some unusual options trading on Tuesday. Stock traders bought 32,950 call options on the company. This is an increase of ...

BEAM), split between ARK's Innovation ETF (ARKK) and ARKG, with a combined dollar value of $788,856. This investment continues a trend, as ARK has been consistently increasing its position in Beam ...

Another notable transaction included the purchase of 23,555 shares of Beam Therapeutics Inc (NASDAQ:BEAM), split between ARK's Innovation ETF (ARKK) and ARKG, with a combined dollar value of $788,856.

In a move that caught the attention of investors, ARK significantly increased its holdings in Beam Therapeutics Inc (NASDAQ:BEAM), purchasing a total of 170,778 shares valued at approximately $5.82 ...

ARK significantly increased its holdings in Beam Therapeutics Inc (NASDAQ:BEAM), purchasing a total of 170,778 shares valued at approximately $5.82 million across its ARKK and ARKG funds.

reflecting the fund's ongoing strategy to optimize its investment portfolio in the face of changing market dynamics. The most substantial trade of the day came from ARK's Genomic Revolution ETF (ARKG) ...

In addition to Twist Bioscience, ARK also increased its stake in Beam Therapeutics Inc (NASDAQ:BEAM) by acquiring a combined 47,127 shares across its ARKK and ARKG ... overall investment strategy of ...